Vergleich

HCV Core 22kDa Protein

ArtNr OPPA00931
Hersteller AVIVA Systems Biology
Menge 100 ug
Kategorie
Typ Proteins Recombinant
Format Liquid
Applikationen WB, ELISA
Specific against HCV (Hepatitis C virus)
Purity HCV-Core Protein is >95% pure as determined by 10% PAGE (coomassie staining).
Sequence mstnpkpqrk tkrntnrrpq dvkfpgvgqi vggvyllprr gprlgvratr ktsersqprg rrqpipkarr pegrtwaqpg ypwplygneg cgwagwllsp rgsrpswgpt dprrrsrnlg kvidtltcgf adlmgyiplv gaplggaara lahgvrvled gvnyatgnlp gcsfsiflla llscltvpa.
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias HCV Core 22kDa,Hepatitis C Virus Core 22kDa Recombinant
Similar products HCV 22kDa
Versandbedingung Gekühlt
Lieferbar
Specificity Hepatitis C Virus
Manufacturer - Type
Protein
Manufacturer - Category
Root Catalog/Products/Recombinant Proteins
Shipping Temperature
Wet Ice
Gene symbol
HCV 22KDA
Protein size
Recombinant
Product format
Liquid. In 20mM Tris Hcl pH-8, 8M urea and 10mM beta-mercaptoethanol.
Reconstitution and storage
HCV-Core although stable at 4C for 1 week, should be stored below -18C. Please prevent freeze thaw cycles.
Description of target
HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6).
Purification
HCV-Core protein was purified by proprietary chromatographic technique.
Manufacturer - Specificity
Immunoreactive with sera of HCV-infected individuals.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 100 ug
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen